Avalo Therapeutics, Inc. Announces Pricing of $27.5 Million Public Offering of Common Stock
WAYNE, Pa. and ROCKVILLE, Md., Sept. 14, 2021 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Avalo or the Company) (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for…
